Editorial: Myeloid-derived suppressor cells in inflammation and its complications and cancers

Xing Li; Dinesh Kumar Ahirwar; Xiang-Yuan Wu

doi:10.3389/fimmu.2023.1240415

Editorial: Myeloid-derived suppressor cells in inflammation and its complications and cancers

Front Immunol. 2023 Jul 18:14:1240415. doi: 10.3389/fimmu.2023.1240415. eCollection 2023.

Authors

Xing Li¹, Dinesh Kumar Ahirwar², Xiang-Yuan Wu¹

Affiliations

¹ Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
² Department of Bioscience & Bioengineering, Indian Institute of Technology Jodhpur, Karwar, Rajasthan, India.

No abstract available

Keywords: cancer; chronic inflammation; erythroid progenitor cells; extramedullary erythropoiesis; myeloid-derived suppressor cells.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Erythropoiesis
Humans
Inflammation
Myeloid-Derived Suppressor Cells*
Neoplasms* / etiology

Grants and funding

This study was supported by the Guangdong Basic and Applied Basic Research Foundation (No. 2021A1515011022, 2023A1515012544, and 2022A1515012659), and Tip-top Scientific and Technical Innovative Youth Talents of the Third Affiliated Hospital of Sun Yat-sen University.